Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Uwe Siebert, M.D.

Title
Institution
Department
Address
Phone
Fax

Biography
2017
Award for Distinguished Service
2013
Leadership and Service Award
2012
David Sackett Award
2011
Award as Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force
2010
Leadership and Service Award
2009
Award for Best Short Course "Causal Inference and Causal Diagrams in Medical Decision Making"
2009
David Sackett Award
2008
ISPOR Leadership Pin
2008
ISPOR Distinguished Service Award
2008
ISPOR Board of Directors Service Award
2008
Best Publication in Journal for Internal Medicine in Hospital and Practice
2004
Award for Outstanding Short Course "Causal Inference and Causal Diagrams in Medical Decision Making"
2003
Award for Evidence-based Medicine
2000
German Award for Pain Research
1999
Paul Martini Research Award in Pharmacoepidemiology
1999
Spitzner-Award Physical and Rehabilitative Medicine
1998
Pain Research Award
1996
Fritz and Hildegard Berg Award for Public Health
1996
Bavarian Public Health Award
1980
Robert Bosch Science Award

Overview

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Jahn B, Kurzthaler C, Chhatwal J, Elbasha EH, Conrads-Frank A, Rochau U, Sroczynski G, Urach C, Bundo M, Popper N, Siebert U. Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness. Med Decis Making. 2019 Jun 28; 272989X19851095. PMID: 31253053.
    Citations:    
  2. Sommer I, Titscher V, Teufer B, Klerings I, Nußbaumer-Streit B, Szelag M, Affengruber L, Wagner G, Glechner A, Kien C, Ebenberger A, Schiller-Frühwirth I, Dorner TE, Siebenhofer A, Haditsch B, Bachler H, Siebert U, Gartlehner G. [Evidence-based recommendations for the revision of the Austrian periodic health examination]. Wien Med Wochenschr. 2019 Jun 11. PMID: 31187373.
    Citations:    
  3. Borba HHL, Rochau U, Wiens A, Sroczynski G, Siebert U, Ferreira VL, Minowa E, Pontarolo R. Effectiveness and Cost-Effectiveness of Triple Therapy with Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from the Brazilian Public Health System Perspective. Value Health Reg Issues. 2019 May 17; 20:95-102. PMID: 31108456.
    Citations:    
  4. Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher I, Malbaski N, Popper N, Chhatwal J, Greenberg D, Mauskopf J, Siebert U. Budget Impact Analysis of Cancer Screening: A Methodological Review. Appl Health Econ Health Policy. 2019 Apr 24. PMID: 31016686.
    Citations:    
  5. Latimer NR, Abrams KR, Siebert U. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring. BMC Med Res Methodol. 2019 Mar 29; 19(1):69. PMID: 30935369.
    Citations:    
  6. Adarkwah CC, Jegan N, Heinzel-Gutenbrunner M, Kühne F, Siebert U, Popert U, Donner-Banzhoff N, Kürwitz S. The Optimizing-Risk-Communication (OptRisk) randomized trial - impact of decision-aid-based consultation on adherence and perception of cardiovascular risk. Patient Prefer Adherence. 2019; 13:441-452. PMID: 30988601.
    Citations:    
  7. Morawetz D, Blank C, Koller A, Arvandi M, Siebert U, Schobersberger W. Sex-Related Differences After a Single Bout of Maximal Eccentric Exercise in Response to Acute Effects: A Systematic Review and Meta-analysis. J Strength Cond Res. 2019 Mar 15. PMID: 30908366.
    Citations:    
  8. Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up. Geburtshilfe Frauenheilkd. 2019 Feb; 79(2):160-176. PMID: 30792546.
    Citations:    
  9. Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia. Geburtshilfe Frauenheilkd. 2019 Feb; 79(2):148-159. PMID: 30792545.
    Citations:    
  10. Stella SF, Polanczyk CA, Arvandi M, Siebert U. Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil. Int J Qual Health Care. 2018 Dec 20. PMID: 30576452.
    Citations:    Fields:    
  11. Kristensen FB, Husereau D, Huic M, Drummond M, Berger ML, Bond K, Augustovski F, Booth A, Bridges JFP, Grimshaw J, IJzerman MJ, Jonsson E, Ollendorf DA, Rüther A, Siebert U, Sharma J, Wailoo A. Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. Value Health. 2019 01; 22(1):13-20. PMID: 30661627.
    Citations:    Fields:    
  12. Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A, Kalss G, Neuray C, Kreidenhuber R, Höfler J, Kuchukhidze G, Granbichler C, Dobesberger J, Novak HF, Pilz G, Meletti S, Siebert U. Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes. Epilepsia. 2019 Jan; 60(1):53-62. PMID: 30478910.
    Citations:    Fields:    
  13. Velickovic VM, Borisenko O, Svensson M, Spelman T, Siebert U. Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model. PLoS One. 2018; 13(9):e0204643. PMID: 30261033.
    Citations:    Fields:    
  14. Velickovic VM, Rochau U, Conrads-Frank A, Kee F, Blankenberg S, Siebert U. Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays. Expert Rev Pharmacoecon Outcomes Res. 2018 12; 18(6):619-640. PMID: 30115001.
    Citations:    Fields:    Translation:Humans
  15. Siebert U, Hallsson LR. To stop or not to stop: a value of information view. Eur J Epidemiol. 2018 Sep; 33(9):785-787. PMID: 30120627.
    Citations:    Fields:    
  16. Völzke H, Erlund I, Hubalewska-Dydejczyk A, Ittermann T, Peeters RP, Rayman M, Buchberger M, Siebert U, Thuesen BH, Zimmermann MB, Grünert S, Lazarus JH. How Do We Improve the Impact of Iodine Deficiency Disorders Prevention in Europe and Beyond? Eur Thyroid J. 2018 Aug; 7(4):193-200. PMID: 30283737.
    Citations:    
  17. Rajsic S, Gothe H, Borba HH, Sroczynski G, Vujicic J, Toell T, Siebert U. Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ. 2019 Feb; 20(1):107-134. PMID: 29909569.
    Citations:    Fields:    
  18. Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E. Health state utilities among contemporary prostate cancer patients on active surveillance. Transl Androl Urol. 2018 Apr; 7(2):197-202. PMID: 29732277.
    Citations:    
  19. Richter AK, Klimek L, Merk HF, Mülleneisen N, Renz H, Wehrmann W, Werfel T, Hamelmann E, Siebert U, Sroczynski G, Wasem J, Biermann-Stallwitz J. Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach. Eur J Health Econ. 2018 Dec; 19(9):1229-1242. PMID: 29574666.
    Citations:    Fields:    
  20. Arvandi M, Strasser B, Volaklis K, Ladwig KH, Grill E, Matteucci Gothe R, Horsch A, Laxy M, Siebert U, Peters A, Thorand B, Meisinger C. Mediator Effect of Balance Problems on Association Between Grip Strength and Falls in Older Adults: Results From the KORA-Age Study. Gerontol Geriatr Med. 2018 Jan-Dec; 4:2333721418760122. PMID: 29568795.
    Citations:    
  21. Widschwendter M, Jones A, Evans I, Reisel D, Dillner J, Sundström K, Steyerberg EW, Vergouwe Y, Wegwarth O, Rebitschek FG, Siebert U, Sroczynski G, de Beaufort ID, Bolt I, Cibula D, Zikan M, Bjørge L, Colombo N, Harbeck N, Dudbridge F, Tasse AM, Knoppers BM, Joly Y, Teschendorff AE, Pashayan N. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat Rev Clin Oncol. 2018 05; 15(5):292-309. PMID: 29485132.
    Citations: 4     Fields:    
  22. Seidl A, Danner M, Wagner CJ, Sandmann FG, Sroczynski G, Stürzlinger H, Zsifkovits J, Schwalm A, Lhachimi SK, Siebert U, Gerber-Grote A. Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants. MDM Policy Pract. 2018 Jan-Jun; 3(1):2381468317751923. PMID: 30288435.
    Citations:    
  23. Latimer NR, White IR, Abrams KR, Siebert U. Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Stat Methods Med Res. 2018 Jan 01; 962280218780856. PMID: 29940824.
    Citations:    Fields:    
  24. Schnell-Inderst P, Hunger T, Conrads-Frank A, Arvandi M, Siebert U. Recommendations for primary studies evaluating therapeutic medical devices were identified and systematically reported through reviewing existing guidance. J Clin Epidemiol. 2018 Feb; 94:46-58. PMID: 29122699.
    Citations:    Fields:    
  25. Schnell-Inderst P, Hunger T, Conrads-Frank A, Arvandi M, Siebert U. Ten recommendations for assessing the comparative effectiveness of therapeutic medical devices: a targeted review and adaptation. J Clin Epidemiol. 2018 Feb; 94:97-113. PMID: 29107757.
    Citations: 1     Fields:    
  26. Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sroczynski G, Paulden M, Bundo M, Stenehjem D, Brixner D, Krahn M, Siebert U. Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online. BMC Cancer. 2017 Oct 16; 17(1):685. PMID: 29037213.
    Citations:    Fields:    Translation:Humans
  27. Jahn B, Arvandi M, Rochau U, Fiegl H, Goebel G, Marth C, Siebert U. Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1. J Comp Eff Res. 2017 Oct; 6(7):563-574. PMID: 29091014.
    Citations: 1     Fields:    
  28. Loeb S, Zhou Q, Siebert U, Rochau U, Jahn B, Mühlberger N, Carter HB, Lepor H, Braithwaite RS. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions. Eur Urol. 2017 12; 72(6):899-907. PMID: 28844371.
    Citations: 2     Fields:    Translation:Humans
  29. Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med. 2018 01; 20(1):132-141. PMID: 28726810.
    Citations: 2     Fields:    Translation:Humans
  30. Mühlberger N, Boskovic K, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Sroczynski G, Siebert U. Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model. BMC Public Health. 2017 06 26; 17(1):596. PMID: 28651567.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  31. Schiller-Frühwirth IC, Jahn B, Arvandi M, Siebert U. Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review. Appl Health Econ Health Policy. 2017 Jun; 15(3):333-351. PMID: 28185134.
    Citations: 1     Fields:    Translation:Humans
  32. Schiller-Fruehwirth I, Jahn B, Einzinger P, Zauner G, Urach C, Siebert U. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria. Value Health. 2017 09; 20(8):1048-1057. PMID: 28964436.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  33. Di Paolo A, Sarkozy F, Ryll B, Siebert U. Personalized medicine in Europe: not yet personal enough? BMC Health Serv Res. 2017 Apr 19; 17(1):289. PMID: 28424057.
    Citations: 1     Fields:    Translation:Humans
  34. Oberaigner W, Geiger-Gritsch S, Edlinger M, Daniaux M, Knapp R, Hubalek M, Siebert U, Marth C, Buchberger W. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria. Breast. 2017 Jun; 33:178-182. PMID: 28419909.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  35. Bose-O'Reilly S, Bernaudat L, Siebert U, Roider G, Nowak D, Drasch G. Signs and symptoms of mercury-exposed gold miners. Int J Occup Med Environ Health. 2017 Mar 30; 30(2):249-269. PMID: 28366955.
    Citations:    Fields:    Translation:HumansPHPublic Health
  36. Czarnecka-Kujawa K, Rochau U, Siebert U, Atenafu E, Darling G, Waddell TK, Pierre A, De Perrot M, Cypel M, Keshavjee S, Yasufuku K. Cost-effectiveness of mediastinal lymph node staging in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017 Jun; 153(6):1567-1578. PMID: 28283236.
    Citations: 1     Fields:    
  37. Schnell-Inderst P, Iglesias CP, Arvandi M, Ciani O, Matteucci Gothe R, Peters J, Blom AW, Taylor RS, Siebert U. A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement. Health Econ. 2017 02; 26 Suppl 1:46-69. PMID: 28139089.
    Citations:    Fields:    Translation:Humans
  38. Arvandi M, Strasser B, Meisinger C, Volaklis K, Gothe RM, Siebert U, Ladwig KH, Grill E, Horsch A, Laxy M, Peters A, Thorand B. Gender differences in the association between grip strength and mortality in older adults: results from the KORA-age study. BMC Geriatr. 2016 11 30; 16(1):201. PMID: 27903239.
    Citations: 6     Fields:    Translation:Humans
  39. Adarkwah CC, Jegan N, Heinzel-Gutenbrunner M, Kühne F, Siebert U, Popert U, Donner-Banzhoff N, Kürwitz S. Time-to-event versus ten-year-absolute-risk in cardiovascular risk prevention - does it make a difference? Results from the Optimizing-Risk-Communication (OptRisk) randomized-controlled trial. BMC Med Inform Decis Mak. 2016 11 29; 16(1):152. PMID: 27899103.
    Citations: 1     Fields:    Translation:Humans
  40. Hunger T, Schnell-Inderst P, Sahakyan N, Siebert U. USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW. Int J Technol Assess Health Care. 2016 Jan; 32(3):131-9. PMID: 27502308.
    Citations: 1     Fields:    
  41. Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WM, Krack P, Timmermann L, Schnitzler A, Reese JP, Dodel R. Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications. Mov Disord. 2016 08; 31(8):1183-91. PMID: 27506638.
    Citations: 3     Fields:    Translation:Humans
  42. Bose-O'Reilly S, Schierl R, Nowak D, Siebert U, William JF, Owi FT, Ir YI. A preliminary study on health effects in villagers exposed to mercury in a small-scale artisanal gold mining area in Indonesia. Environ Res. 2016 08; 149:274-281. PMID: 27174690.
    Citations: 3     Fields:    Translation:HumansAnimalsPHPublic Health
  43. Willenbacher E, Weger R, Rochau U, Siebert U, Willenbacher W. Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics. PLoS One. 2016; 11(3):e0147381. PMID: 26937956.
    Citations: 4     Fields:    Translation:Humans
  44. Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. Pharmacoeconomics. 2016 Mar; 34(3):227-44. PMID: 26477039.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  45. Völzke H, Caron P, Dahl L, de Castro JJ, Erlund I, Gaberšcek S, Gunnarsdottir I, Hubalewska-Dydejczyk A, Ittermann T, Ivanova L, Karanfilski B, Khattak RM, Kusic Z, Laurberg P, Lazarus JH, Markou KB, Moreno-Reyes R, Nagy EV, Peeters RP, Pirags V, Podoba J, Rayman MP, Rochau U, Siebert U, Smyth PP, Thuesen BH, Troen A, Vila L, Vitti P, Zamrazil V, Zimmermann MB. Ensuring Effective Prevention of Iodine Deficiency Disorders. Thyroid. 2016 Feb; 26(2):189-96. PMID: 26700864.
    Citations: 3     Fields:    Translation:Humans
  46. Luzak A, Schnell-Inderst P, Bühn S, Mayer-Zitarosa A, Siebert U. Clinical effectiveness of cancer screening biomarker tests offered as self-pay health service: a systematic review. Eur J Public Health. 2016 06; 26(3):498-505. PMID: 26733629.
    Citations:    Fields:    Translation:Humans
  47. Latimer NR, Henshall C, Siebert U, Bell H. TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES. Int J Technol Assess Health Care. 2016 Jan; 32(3):160-6. PMID: 27624982.
    Citations: 2     Fields:    Translation:Humans
  48. Christensen KD, Dukhovny D, Siebert U, Green RC. Assessing the Costs and Cost-Effectiveness of Genomic Sequencing. J Pers Med. 2015 Dec 10; 5(4):470-86. PMID: 26690481.
    Citations: 21     
  49. Rochau U, Kluibenschaedl M, Stenehjem D, Kuan-Ling K, Radich J, Oderda G, Brixner D, Siebert U. Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis. Leuk Res Treatment. 2015; 2015:982395. PMID: 26783469.
    Citations: 2     
  50. Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sroczynski G, Paulden M, Kluibenschädl M, Krahn M, Siebert U. Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria. Springerplus. 2015; 4:752. PMID: 26693110.
    Citations: 2     
  51. Stenehjem DD, Bellows BK, Yager KM, Jones J, Kaldate R, Siebert U, Brixner DI. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer. Oncologist. 2016 Feb; 21(2):196-204. PMID: 26614710.
    Citations: 1     Fields:    Translation:Humans
  52. Rochau U, Vukicevic D, Schmidt S, Stenehjem D, Brixner D, Radich J, Gastl G, Siebert U. COST-EFFECTIVENESS ANALYSIS ON STARTING PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB. Value Health. 2015 Nov; 18(7):A462. PMID: 26532598.
    Citations:    Fields:    
  53. Buchberger M, Rochau U, Vukicevic D, Willenbacher W, Siebert U. TREATMENT STRATEGIES FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A META-ANALYSIS AND INDIRECT TREATMENT COMPARISON. Value Health. 2015 Nov; 18(7):A432. PMID: 26532434.
    Citations:    Fields:    
  54. Jahn B, Rochau U, Kurzthaler C, Paulden M, Kluibenschädl M, Arvandi M, Kühne F, Goehler A, Krahn MD, Siebert U. Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment. Med Decis Making. 2016 04; 36(3):375-90. PMID: 26476865.
    Citations: 3     Fields:    Translation:Humans
  55. Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Muehlberger N, Flatscher-Thoeni M, Schnell-Inderst P, Sroczynski G, Lackner M, Schall I, Hebborn A, Pugner K, Fehervary A, Brixner D, Siebert U. Systematic overview of cost-effectiveness thresholds in ten countries across four continents. J Comp Eff Res. 2015 Sep; 4(5):485-504. PMID: 26490020.
    Citations: 6     Fields:    Translation:Humans
  56. Gothe H, Schall I, Saverno K, Mitrovic M, Luzak A, Brixner D, Siebert U. The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review. Appl Health Econ Health Policy. 2015 Aug; 13 Suppl 1:S21-33. PMID: 26091709.
    Citations: 6     Fields:    Translation:Humans
  57. Siebert U, Jahn B, Rochau U, Schnell-Inderst P, Kisser A, Hunger T, Sroczynski G, Mühlberger N, Willenbacher W, Schnaiter S, Endel G, Huber L, Gastl G. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research. Z Evid Fortbild Qual Gesundhwes. 2015; 109(4-5):330-40. PMID: 26354133.
    Citations: 1     Fields:    Translation:Humans
  58. Schnell-Inderst P, Mayer J, Lauterberg J, Hunger T, Arvandi M, Conrads-Frank A, Nachtnebel A, Wild C, Siebert U. Health technology assessment of medical devices: What is different? An overview of three European projects. Z Evid Fortbild Qual Gesundhwes. 2015; 109(4-5):309-18. PMID: 26354131.
    Citations: 3     Fields:    Translation:Humans
  59. Leichtfried V, Basic D, Burtscher M, Gothe RM, Siebert U, Schobersberger W. Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude? Sleep Breath. 2016 Mar; 20(1):435-42. PMID: 26032284.
    Citations: 2     Fields:    Translation:Humans
  60. Mühlberger N, Kurzthaler C, Iskandar R, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U. The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening. Med Decis Making. 2015 08; 35(6):758-72. PMID: 25977360.
    Citations: 2     Fields:    Translation:Humans
  61. Geiger-Gritsch S, Oberaigner W, Mühlberger N, Siebert U, Ladurner M, Klocker H, Horninger W. Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck. Urol Int. 2015; 94(4):419-27. PMID: 25662301.
    Citations: 1     Fields:    Translation:Humans
  62. Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Kluibenschaedl M, Conrads-Frank A, Stenehjem D, Brixner D, Radich J, Gastl G, Siebert U. Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. Leuk Lymphoma. 2015; 56(8):2315-25. PMID: 25393806.
    Citations: 7     Fields:    Translation:Humans
  63. Rogowski W, Payne K, Schnell-Inderst P, Manca A, Rochau U, Jahn B, Alagoz O, Leidl R, Siebert U. Concepts of 'personalization' in personalized medicine: implications for economic evaluation. Pharmacoeconomics. 2015 Jan; 33(1):49-59. PMID: 25249200.
    Citations: 16     Fields:    Translation:Humans
  64. Rochau U, Jahn B, Qerimi V, Burger EA, Kurzthaler C, Kluibenschaedl M, Willenbacher E, Gastl G, Willenbacher W, Siebert U. Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example. Crit Rev Oncol Hematol. 2015 May; 94(2):164-78. PMID: 25620327.
    Citations: 2     Fields:    Translation:Humans
  65. Steckling N, Bose-O'Reilly S, Pinheiro P, Plass D, Shoko D, Drasch G, Bernaudat L, Siebert U, Hornberg C. The burden of chronic mercury intoxication in artisanal small-scale gold mining in Zimbabwe: data availability and preliminary estimates. Environ Health. 2014 Dec 13; 13:111. PMID: 25495641.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  66. Oostvogels AJ, De Wit GA, Jahn B, Cassini A, Colzani E, De Waure C, Kretzschmar ME, Siebert U, Mühlberger N, Mangen MJ. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review. Epidemiol Infect. 2015 Jul; 143(9):1791-802. PMID: 25499823.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  67. Neumann A, Mostardt S, Biermann J, Gelbrich G, Goehler A, Geisler BP, Siebert U, Störk S, Ertl G, Angerrmann CE, Wasem J. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study. Clin Res Cardiol. 2015 Apr; 104(4):304-9. PMID: 25403774.
    Citations: 4     Fields:    Translation:Humans
  68. Rochau U, Schnell-Inderst P, Burger EA, Baldauf M, Kühne F, Jahn B, Siebert U. Systematic Overview On Value-Of Information Analyses In Cancer Research. Value Health. 2014 Nov; 17(7):A559. PMID: 27201842.
    Citations:    Fields:    
  69. Hunger T, Schnell-Inderst P, Arvandi M, Conrads-Frank A, Siebert U. Comparative Effectiveness Research of Medical Devices - New Methods Needed? Value Health. 2014 Nov; 17(7):A582. PMID: 27201970.
    Citations:    Fields:    
  70. Jahn B, Rochau U, Shterjovska J, Kurzthaler C, Kluibenschädl M, Urach C, Einzinger P, Piringer H, Popper N, Siebert U. Visualizing Methods For Discrete-Event-Simulations Using The Example Of A Breast Cancer Decision-Analytic Model. Value Health. 2014 Nov; 17(7):A562. PMID: 27201856.
    Citations:    Fields:    
  71. Kuehne F, Rochau U, Paracha N, Sabate E, Siebert U. Estimating Crossover Bias In A Randomized Clinical Trial Of Ovarian Cancer Treatment. Value Health. 2014 Nov; 17(7):A564. PMID: 27201868.
    Citations:    Fields:    
  72. Rochau U, Kluibenschaedl M, Stenehjem D, Kuo KL, Oderda G, Brixner D, Siebert U. Decision Analysis on the Cost-Effectiveness of Sequential Treatment Strategies for Patients with Chronic Myeloid Leukemia in the United States. Value Health. 2014 Nov; 17(7):A639. PMID: 27202283.
    Citations:    Fields:    
  73. Mühlberger N, Heijnsdijk EA, Kurzthaler C, Iskandar R, Krahn MD, Bremner K, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U. The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening. Value Health. 2014 Nov; 17(7):A559. PMID: 27201843.
    Citations:    Fields:    
  74. Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote AU, Greiner W, Hanquet G, Harder T, Hutubessy R, Jit M, Knol M, Kuhlmann A, von Kries R, Levy-Bruhl D, Perleth M, Postma MJ, Salo H, Siebert U, Wasem J, Weidemann F, Wichmann O. Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop. Value Health. 2014 Nov; 17(7):A552. PMID: 27201800.
    Citations: 1     Fields:    
  75. Rochau U, Kühne F, Jahn B, Kurzthaler C, Corro RI, Chhatwal J, Stollenwerk B, Goldhaber-Fiebert JD, Siebert U. Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis. Value Health. 2014 Nov; 17(7):A639. PMID: 27202284.
    Citations:    Fields:    
  76. Glogger M, Schnell-Inderst P, Luzak A, Krueger A, Siebert U. New Reimbursement Schemes for Stratified Medicine in Oncology - A Systematic Review. Value Health. 2014 Nov; 17(7):A663. PMID: 27202420.
    Citations:    Fields:    
  77. Diaby V, Goeree R, Hoch J, Siebert U. Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb; 15(1):13-9. PMID: 25267699.
    Citations: 1     Fields:    Translation:Humans
  78. Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, Ruijter Hd, Schnabel RB, Kee F, Salomaa V, Siebert U, Thorand B, Ziegler A, Breek H, Pasterkamp G, Kuulasmaa K, Koenig W, Blankenberg S. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014 Oct; 29(10):777-90. PMID: 25238720.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  79. Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U. Systematic assessment of decision-analytic models for chronic myeloid leukemia. Appl Health Econ Health Policy. 2014 Apr; 12(2):103-15. PMID: 24385259.
    Citations: 1     Fields:    Translation:Humans
  80. Williams R, Kelly N, Boebel O, Friedlaender AS, Herr H, Kock KH, Lehnert LS, Maksym T, Roberts J, Scheidat M, Siebert U, Brierley AS. Counting whales in a challenging, changing environment. Sci Rep. 2014 Mar 13; 4:4170. PMID: 24622821.
    Citations: 1     Fields:    Translation:Animals
  81. Stollenwerk B, Lhachimi SK, Briggs A, Fenwick E, Caro JJ, Siebert U, Danner M, Gerber-Grote A. Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers. Health Econ. 2015 Apr; 24(4):481-90. PMID: 24590819.
    Citations:    Fields:    Translation:Humans
  82. Saverno K, Gothe H, Schuessel K, Biskupiak J, Schulz M, Siebert U, Brixner D. Consideration of international generic distribution policies on patient outcomes in the United States and Germany. Pharmazie. 2014 Mar; 69(3):238-40. PMID: 24716417.
    Citations: 2     Fields:    Translation:Humans
  83. Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y. Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt. Clin Infect Dis. 2014 Apr; 58(8):1064-71. PMID: 24510934.
    Citations: 7     Fields:    Translation:Humans
  84. Rochau U, Sroczynski G, Wolf D, Schmidt S, Conrads-Frank A, Jahn B, Saverno K, Brixner D, Radich J, Gastl G, Siebert U. Medical decision analysis for first-line therapy of chronic myeloid leukemia. Leuk Lymphoma. 2014 Aug; 55(8):1758-67. PMID: 24160847.
    Citations: 2     Fields:    Translation:Humans
  85. Siebert U, Arvandi M, Gothe RM, Bornschein B, Eccleston D, Walters DL, Rankin J, De Bruyne B, Fearon WF, Pijls NH, Harper R. Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR-guided PCI. Heart Lung Circ. 2014 Jun; 23(6):527-33. PMID: 24560401.
    Citations: 7     Fields:    
  86. Weinberger B, Schirmer M, Matteucci Gothe R, Siebert U, Fuchs D, Grubeck-Loebenstein B. Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. PLoS One. 2013; 8(12):e82967. PMID: 24349407.
    Citations: 12     Fields:    Translation:HumansCellsCTClinical Trials
  87. Rautenberg T, Siebert U, Arnold D, Bennouna J, Kubicka S, Walzer S, Ngoh C. Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer. J Med Econ. 2014 Feb; 17(2):99-110. PMID: 24215550.
    Citations:    Fields:    Translation:Humans
  88. Siebert U, Rochau U, Claxton K. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence. Z Evid Fortbild Qual Gesundhwes. 2013; 107(9-10):575-84. PMID: 24315327.
    Citations: 4     Fields:    Translation:Humans
  89. Caro JJ, Eddy DM, Hollingworth W, Tsevat J, McDonald KM, Wong JB, Briggs AH, Siebert U, Kuntz KM. ISPOR-SMDM task force's recommendations for good modeling practices-reply to letter to the editor by Corro Ramos. Value Health. 2013 Sep-Oct; 16(6):1108. PMID: 24041365.
    Citations:    Fields:    
  90. Sroczynski G, Siebert U. Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C. Nat Rev Gastroenterol Hepatol. 2013 Oct; 10(10):572-4. PMID: 23958602.
    Citations:    Fields:    Translation:HumansCells
  91. Hunger T, Schnell-Inderst P, Hintringer K, Schwarzer R, Seifert-Klauss V, Gothe H, Wasem J, Siebert U. Health technology assessment of utilization, practice and ethical issues of self-pay services in the German ambulatory health care setting. Int J Public Health. 2014 Feb; 59(1):175-87. PMID: 23903284.
    Citations:    Fields:    Translation:Humans
  92. Sulz MC, Siebert U, Arvandi M, Gothe RM, Wurm J, von Känel R, Vavricka SR, Meyenberger C, Sagmeister M. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study. Eur J Gastroenterol Hepatol. 2013 Jul; 25(7):790-7. PMID: 23571609.
    Citations: 10     Fields:    Translation:Humans
  93. Dams J, Siebert U, Bornschein B, Volkmann J, Deuschl G, Oertel WH, Dodel R, Reese JP. Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease. Mov Disord. 2013 Jun; 28(6):763-71. PMID: 23576266.
    Citations: 12     Fields:    Translation:Humans
  94. Dams J, Klotsche J, Bornschein B, Reese JP, Balzer-Geldsetzer M, Winter Y, Schrag A, Siderowf A, Oertel WH, Deuschl G, Siebert U, Dodel R. Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease. Health Qual Life Outcomes. 2013 Mar 08; 11:35. PMID: 23497005.
    Citations: 5     Fields:    Translation:Humans
  95. Siebert U, Wurm J, Gothe RM, Arvandi M, Vavricka SR, von Känel R, Begré S, Sulz MC, Meyenberger C, Sagmeister M. Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):847-55. PMID: 23446333.
    Citations: 11     Fields:    Translation:Humans
  96. Stollenwerk B, Gandjour A, Lüngen M, Siebert U. Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation. Eur J Health Econ. 2013 Dec; 14(6):1035-48. PMID: 23275043.
    Citations: 2     Fields:    
  97. Blatt CR, Bernardo NLMDC, Rosa JA, Bagatini F, Alexandre RF, Balbinotto Neto G, Siebert U, Rocha Farias M. An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System. Value Health Reg Issues. 2012 Dec; 1(2):129-135. PMID: 29702891.
    Citations: 1     Fields:    
  98. Faulkner E, Annemans L, Garrison L, Helfand M, Holtorf AP, Hornberger J, Hughes D, Li T, Malone D, Payne K, Siebert U, Towse A, Veenstra D, Watkins J. Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group. Value Health. 2012 Dec; 15(8):1162-71. PMID: 23244820.
    Citations: 17     Fields:    Translation:Humans
  99. Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. Value Health. 2012 Sep-Oct; 15(6):796-803. PMID: 22999128.
    Citations: 86     Fields:    
  100. Verhoef TI, Redekop WK, van Schie RM, Bayat S, Daly AK, Geitona M, Haschke-Becher E, Hughes DA, Kamali F, Levin LÅ, Manolopoulos VG, Pirmohamed M, Siebert U, Stingl JC, Wadelius M, de Boer A, Maitland-van der Zee AH. Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Pharmacogenomics. 2012 Sep; 13(12):1405-17. PMID: 22966889.
    Citations: 6     Fields:    Translation:Humans
  101. Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making. 2012 Sep-Oct; 32(5):690-700. PMID: 22990084.
    Citations: 34     Fields:    
  102. Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Making. 2012 Sep-Oct; 32(5):667-77. PMID: 22990082.
    Citations: 42     Fields:    
  103. Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. Value Health. 2012 Sep-Oct; 15(6):812-20. PMID: 22999130.
    Citations: 62     Fields:    
  104. Luce BR, Drummond MF, Dubois RW, Neumann PJ, Jönsson B, Siebert U, Schwartz JS. Principles for planning and conducting comparative effectiveness research. J Comp Eff Res. 2012 Sep; 1(5):431-40. PMID: 24236420.
    Citations: 5     Fields:    Translation:Humans
  105. Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P. Predicted effects of treatment for HCV infection vary among European countries. Gastroenterology. 2012 Oct; 143(4):974-85.e14. PMID: 22863764.
    Citations: 23     Fields:    Translation:HumansCellsPHPublic Health
  106. Saverno KR, Rochau U, Stenehjem DD, Morley K, Siebert U, Brixner DI. Application of decision-analytic models in personalized medicine for CML treatment decisions made by payers, providers, and patients. J Manag Care Pharm. 2012 Jul-Aug; 18(6):457-63. PMID: 22839687.
    Citations: 2     Fields:    Translation:Humans
  107. Dimai HP, Redlich K, Peretz M, Borgström F, Siebert U, Mahlich J. Economic burden of osteoporotic fractures in Austria. Health Econ Rev. 2012 Jun 27; 2(1):12. PMID: 22827971.
    Citations: 11